Wells Fargo’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $24.5K | Buy |
|
|||||
|
2023
Q4 | $12K | Buy |
|
|||||
|
2023
Q3 | $12.1K | Sell |
|
|||||
|
2023
Q2 | $44.2K | Buy |
|
|||||
|
2023
Q1 | $32.8K | Buy |
|
|||||
|
2022
Q4 | $5.02K | Sell |
|
|||||
|
2022
Q3 | $19K | Sell |
|
|||||
|
2022
Q2 | $24K | Sell |
|
|||||
|
2022
Q1 | $193K | Sell |
|
|||||
|
2021
Q4 | $334K | Buy |
|
|||||
|
2021
Q3 | $384K | Sell |
|
|||||
|
2021
Q2 | $854K | Buy |
|
|||||
|
2021
Q1 | $460K | Sell |
|
|||||
|
2020
Q4 | $1.09M | Sell |
|
|||||
|
2020
Q3 | $813K | Sell |
|
|||||
|
2020
Q2 | $1.65M | Buy |
|
|||||
|
2020
Q1 | $458K | Buy |
|
|||||
|
2019
Q4 | $469K | Buy |
|
|||||
|
2019
Q3 | $47K | Buy |
|
|||||
|
2019
Q2 | $1K | Buy |
|